Skip to main content
. 2023 Nov 14;13:1283951. doi: 10.3389/fonc.2023.1283951

Table 4.

Immunohistochemistry analysis of xenograft nodule sections.

(A) % Ki67+ cells/nuclei
Drug HCC827 RA1 RB1 RA2
Vehicle 32.6 ± 3.2 28.1 ± 4.2 25.4 ± 3.2 33.9 ± 3.2
Gefitinib 25.3 ± 6.5* n.d. 32.6 ± 8.9 n.d.
MEN1611 24.7 ± 5.8* 29.6 ± 8.4 28.5 ± 6.5 30.4 ± 5.5
Gefitinib+MEN1611 n.d. n.d. 37.1 ± 3.9** n.d.